Device type · JJW
Urinalysis Controls (Assayed And Unassayed)
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JJW
Clinical Chemistry
Device class
Class I
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Urinalysis Controls (Assayed And Unassayed)
- Product code
- JJW
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JJW
Latest FDA decisions
- UA-Cellular Complete510(k)
K170091 · Decided Feb 9, 2017 · 30 days after receipt
Device type: Urinalysis Controls (Assayed And Unassayed) (JJW) · Laboratory Medicine & Pathology
- AUTION CHECK PLUS510(k)
K142262 · Decided Apr 10, 2015 · 239 days after receipt
Device type: Urinalysis Controls (Assayed And Unassayed) (JJW) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Vivoo Sodium Test; Vivoo Vitamin C Test; Vivoo Hydration TestOpen, Classified
Changchun Wancheng Bio-Electron Co., Ltd.
Z-1267-2026 · Started Nov 22, 2025 · Posted by FDA Feb 4, 2026
Reason given: Test strips and other tests including for near-patient testing, that require a 510(k) were distributed before they could be legally marketed to U.S. customers; devices may cause false or inaccurate diagnostic result by lay person and lead to inappropriate medical intervention.
Cause as FDA categorized it: No Marketing Application
Mckesson Medical-Surgical Inc. Corporate Office
Z-0138-2025 · Started Sep 17, 2024 · Posted by FDA Oct 22, 2024
Reason given: The Quantimetrix Dipper Urinalysis Dipstick control was shipped without the validated summer packaging and may have been exposed to temperatures above 25C. This may lead to delay in patients' results.
Cause as FDA categorized it: Packaging process control
- Beckman Coulter IRISPEC CA/CB/CC Urine Chemistry Controls, Catalog Number REF 800-7211 and 800-7702, in vitro diagnostic device.Open, Classified
Z-0093-2025 · Started Jul 16, 2024 · Posted by FDA Oct 16, 2024
Reason given: Beckman Coulter has become aware of an increase in customer complaints for intermittent IRISpec CB negative glucose control failure, resulting in false positive control results when used in conjunction with iChemVELOCITY Urine Chemistry Strips (PNs 800-7204 and 800-7212) on the iChemVELOCITY Analyzer. This issue may...
Cause as FDA categorized it: Under Investigation by firm
19 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.